![](https://i.imgur.com/CLvY2jA.png")
10-08-2023, 09:21 AM
The new shots are designed to target the XBB variants — strains of the virus descended from the original Omicron variant — which are now the most common form in circulation.
Three vaccine manufacturers, Moderna, Pfizer and Novavax, are expected to offer the revised shots for this fall, which virtually all children and adults will be eligible for.
"The intent is to harmonize for all doses, all ages, same composition. So in the fall, that would be the 2023-2024 formula, would be an XBB.1.5," the FDA's Dr. David Kaslow said in June at the CDC meeting.
While newer XBB descendants have since emerged — including EG.5, a strain that's rapidly gaining ground — experts say these variants so far remain closely related, and the updated vaccine formula should offer protection..
https://www.cbsnews.com/news/covid-vacci...mber-2023/
Three vaccine manufacturers, Moderna, Pfizer and Novavax, are expected to offer the revised shots for this fall, which virtually all children and adults will be eligible for.
"The intent is to harmonize for all doses, all ages, same composition. So in the fall, that would be the 2023-2024 formula, would be an XBB.1.5," the FDA's Dr. David Kaslow said in June at the CDC meeting.
While newer XBB descendants have since emerged — including EG.5, a strain that's rapidly gaining ground — experts say these variants so far remain closely related, and the updated vaccine formula should offer protection..
https://www.cbsnews.com/news/covid-vacci...mber-2023/
